UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia

NCT01325298 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mercy Center for Corrective Eye Surgery